146 related articles for article (PubMed ID: 11149118)
1. Dexamethasone does not affect vasopressin release in bronchopulmonary dysplasia.
Zanardo V; Golin R; Chiozza ML; Faggian D
Pediatr Nephrol; 2000 Dec; 15(3-4):241-4. PubMed ID: 11149118
[TBL] [Abstract][Full Text] [Related]
2. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
3. Control of water balance in infants with bronchopulmonary dysplasia: role of endogenous vasopressin.
Hazinski TA; Blalock WA; Engelhardt B
Pediatr Res; 1988 Jan; 23(1):86-8. PubMed ID: 3340451
[TBL] [Abstract][Full Text] [Related]
4. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
[TBL] [Abstract][Full Text] [Related]
5. Changes in vasopressin, atrial natriuretic factor, and water homeostasis in the early stage of bronchopulmonary dysplasia.
Kojima T; Fukuda Y; Hirata Y; Matsuzaki S; Kobayashi Y
Pediatr Res; 1990 Mar; 27(3):260-3. PubMed ID: 2138727
[TBL] [Abstract][Full Text] [Related]
6. [Dexamethasone therapy in bronchopulmonary dysplasia].
Merz U; Kuehl G; Linderkamp O
Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
[TBL] [Abstract][Full Text] [Related]
8. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
Kazzi NJ; Brans YW; Poland RL
Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
[TBL] [Abstract][Full Text] [Related]
11. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Shenai JP; Mellen BG; Chytil F
Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
[TBL] [Abstract][Full Text] [Related]
12. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
[TBL] [Abstract][Full Text] [Related]
13. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.
Skinner AM; Battin M; Solimano A; Daaboul J; Kitson HF
Am J Perinatol; 1997 Oct; 14(9):539-46. PubMed ID: 9394163
[TBL] [Abstract][Full Text] [Related]
14. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone does not prevent catabolic side effects of dexamethasone in extremely low birth weight preterm infants with bronchopulmonary dysplasia--a pilot study.
Tonini G; Pahor T; Colonna F; de Vonderweid U
J Pediatr Endocrinol Metab; 1997; 10(3):291-4. PubMed ID: 9388821
[TBL] [Abstract][Full Text] [Related]
16. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia.
Van Goudoever JB; Wattimena JD; Carnielli VP; Sulkers EJ; Degenhart HJ; Sauer PJ
J Pediatr; 1994 Jan; 124(1):112-8. PubMed ID: 8283359
[TBL] [Abstract][Full Text] [Related]
17. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
Cuna A; Lewis T; Dai H; Nyp M; Truog WE
Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.
Aghai ZH; Saslow JG; Meniru C; Porter C; Eydelman R; Bhat V; Stahl G; Sannoh S; Pyon K; Hewitt C; Bhandari V
J Perinatol; 2010 Sep; 30(9):610-5. PubMed ID: 20182437
[TBL] [Abstract][Full Text] [Related]
20. [From classic to new bronchopulmonary dysplasia].
Kramer BW; Lievense S; Been JV; Zimmermann LJ
Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
